Cite
HARVARD Citation
Xie, C. et al. (2022). Efficacy and toxicity of carfilzomib- or bortezomib-based regimens for treatment of transplant-ineligible patients with newly diagnosed multiple myeloma: A meta-analysis. Medicine. 101 (39), pp. e30715-. [Online].